Faecal parameters in the assessment of activity in inflammatory bowel disease

Scandinavian Journal of Gastroenterology, Supplement

Volumn 33, Issue 34, 1999, Pages 106-110

  Van Der Sluys Veer, A ^a   Biemond, I ^a   Verspaget, H W ^a   Lamers, C B H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1 antitrypsin; Crohn's disease; Faeces; Inflammatory bowel disease; Laboratory diagnosis; Lactoferrin; Lysozyme; PMN elastase; Tumour necrosis factor ; Ulcerative colitis

Indexed keywords

ALPHA 1 ANTITRYPSIN; BARIUM; ESTERASE; HEMOGLOBIN; IMMUNOGLOBULIN A; INDIUM 111; LACTOFERRIN; LEUKOCYTE ELASTASE; LYSOZYME; METHYLPREDNISOLONE; PROTEIN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; ENZYME IMMUNOASSAY; FECES; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMAGING; IMMUNODIFFUSION; INTESTINE BIOPSY; NEPHELOMETRY; PRIORITY JOURNAL; ULCERATIVE COLITIS; CHEMISTRY; CYTOLOGY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIFFERENTIAL DIAGNOSIS; LEUKOCYTE; METABOLISM; PATHOLOGY; REPRODUCIBILITY; REVIEW;

ALPHA 1-ANTITRYPSIN; DIAGNOSIS, DIFFERENTIAL; FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; LABORATORY TECHNIQUES AND PROCEDURES; LACTOFERRIN; LEUKOCYTE ELASTASE; LEUKOCYTES; MURAMIDASE; REPRODUCIBILITY OF RESULTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032610390     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brignola C, Lanfranchi GA, Carapieri M, et al. Importance of laboratory parameters in the evaluation of Crohn's disease activity. J Clin Gastroenterol 1986;8:245-8.
2. Beck IT. Laboratory assessment of inflammatory bowel disease. Dig Dis Sci 1987;32 Suppl 12:26S-41S.
3. Lobo AJ, Sobala GM, Juby LD, Jones SC, Rathbone BJ, Axon ATR. Evaluation of indices for disease activity in Crohn's disease by consensus analysis. Eur J Gastroenterol Hepatol 1991;3:663-6.
4. Tromm A, Tromm CD, Huppe D, Schwegler U, Krieg M, May B. Evaluation of different laboratory tests and activity indices reflecting the inflammatory activity of Crohn's disease. Scand J Gastroenterol 1992;27:774-8.
5. Kieldsen J. Assessment of disease activity in inflammatory bowel disease. Scand J Gastroenterol 1993;28:1-9.
6. Cellier C, Sahmoud T, Froguel E, et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. Gut 1994;35:231-5.
7. Tromm A, Huppe D, Eckenberg K, Schwegler U, Krieg M, May B. Laboratory tests and activity indices in acute ulcerative colitis with respect to the extent of the disease. Eur J Gastroenterol Hepatol 1993;5:21-5.
8. Truelove SC, Wilts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-62.
9. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77:843-6.
10. van Hees PA, van Elteren PH, van Lier HJ, van Tongeren JH. An index of inflammatory activity in patients with Crohn's disease. Gut 1980;21:279-86.
11. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;1:514.
12. Tongeren JH, van Reichert WJ. Demonstration of protein-losing gastroenteropathy. The quantitative estimation of gastrointestinal protein loss, using 51Cr-labelled plasma proteins. Clin Chim Acta 1966;14:42-8.
13. Beeken WL, Busch HJ, Sylvester DL. Intestinal protein loss in Crohn's disease. Gastroenterology 1972;62:207-15.
14. Nordgren S, Hellberg R, Cederblad A, Fasth S, Lindstedt G, Hulten L. Fecal excretion of radiolabeled (51CrCl3) proteins in patients with Crohn's disease. Scand J Gastroenterol 1990;25: 345-51.
15. Crossley JR, Elliott BE. Simple method for diagnosing protein-losing enteropathy. Br Med J 1977;1:428-9.
16. Haeney MR, Fields J, Thompson RA, Asquitt P. Is faecal alpha1-antitrypsin excretion a reliable screening test for protein-losing enteropathy? Lancet 1978;2:1161-2.
17. Bernier JJ, Florent Ch, Desmazurres Ch, Aymes Ch, l'Hirondel ChL. Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin. Lancet 1978;2:760-4.
18. Keaney NP, Kelleher J. Faecal excretion of alpha1-antitrypsin in protein-losing enteropathy. Lancet 1980;2:711.
19. Florent C, l'Hirondel C, Desmazurres C, Aymes C, Bernier J. Intestinal clearance of alpha1-antitrypsin: a sensitive method for detection of protein-losing enteropathy. Gastroenterology 1981; 81:777-80.
20. Hill RE, Hercz A, Corey ML, Hamilton JR. Faecal clearance of alpha1-antitrypsin: a reliable measure of enteric protein loss in children. J Pedriatr 1981;99:416-8.
21. Carrell RW. Alpha1-antitrypsin: molecular pathology, leukocytes and tissue damage. J Clin Invest 1986;78:1427-31.
22. Perlmutter DH, Daniels JD, Auerbach HS, De Schrijver-Keeskemetti K, Winter HS, Alpers DH. The alpha1-antitrypsin gene is expressed in human epithelial cell line. J Biol Chem 1989;264:9485-90.